Does SECUKINUMAB Cause Gait inability? 2,216 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,216 reports of Gait inability have been filed in association with SECUKINUMAB (COSENTYX). This represents 1.5% of all adverse event reports for SECUKINUMAB.
2,216
Reports of Gait inability with SECUKINUMAB
1.5%
of all SECUKINUMAB reports
1,230
Deaths
1,457
Hospitalizations
How Dangerous Is Gait inability From SECUKINUMAB?
Of the 2,216 reports, 1,230 (55.5%) resulted in death, 1,457 (65.7%) required hospitalization, and 1,314 (59.3%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 2,216 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
INFLIXIMAB (1,824)
Which SECUKINUMAB Alternatives Have Lower Gait inability Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG